Google Cloud Healthcare The Netherlands

Clear.bio

Data Lake / Data Warehouse Modernization · Marketing Personalization · Real-time Analytics

Clear.bio is transforming diabetes management by using Google AI to scale its personalized digital nutritional interventions through automated data prediction workflows, thus replacing inefficient manual processes. As Clear.bio 's impact grew across the Netherlands and expanded into Germany and France, they encountered a critical two-fold challenge that hindered their ability to scale effectively.

, a health-tech startup founded in 2019, offers a 12-week digital nutritional intervention to help thousands reverse Type 2 Diabetes using personalized data instead of medication.
69% of patients saw a clinically meaningful HbA1c drop
AI model achieves 92-94% prediction accuracy
Clear.bio sees 30% lift in high-value partner conversion rate

Reported impact

Business outcome

Clear.bio sees 30% lift in high-value partner conversion rate; Sales focus on top 20% practices led to ~20% less outreach time; AI model achieves 92-94% prediction accuracy; 69% of patients saw a clinically meaningful HbA1c drop.

  • Cost Reduction
  • Productivity Improvement
  • Revenue Growth
  • Scalability

Solution

To turn these challenges into opportunities, Clear.bio embarked on an AI Sprint with Google for Startups, integrating a powerful suite of Google AI tools into their core operations. They strategically leveraged Gemini to identify medical practices that fit their growth strategy, using the model to analyze crucial factors like technology adoption, patient demographics, and treatment patterns. This allowed Clear.bio to pinpoint practices with the highest potential for successful referrals. For the predictive heavy lifting, they used Gemini Enterprise Agent Platform to train and deploy a high-accuracy machine learning model, which makes the final predictions and delivers the 'Best_Class' score. Furthermore, BigQuery served as the robust data warehouse, loading, extracting, and preprocessing the extensive data used for training the AutoML model. To automate the entire pipeline, Google

Data flow

stored or unified in BigQuery, orchestrated via Gemini Enterprise Agent Platform, and surfaced through Gemini Enterprise, Gemini, Cloud Run

Solution architecture

5 components · 3 layers
  1. Storage
    • BigQuery Stores and queries the analytics and AI-ready datasets that power the workload.
  2. Serving
    • Gemini Enterprise Provides a secure enterprise environment for teams to use Gemini with governed data access.
    • Gemini Powers natural-language reasoning, summarization, generation, or assistance inside the workflow.
    • Cloud Run Runs application services and proprietary code in a managed container environment.
  3. Orchestration
    • Gemini Enterprise Agent Platform Provides governed enterprise access to Gemini models, agents, and regional controls.

Architecture clues

  • AI model achieves 92-94% prediction accuracy
  • Cloud Run functions were utilized, triggering the process whenever new CSV files were uploaded and managing the end-to-end data flow.

Evidence from the source

69% of patients saw a clinically meaningful HbA1c drop
AI model achieves 92-94% prediction accuracy
Clear.bio sees 30% lift in high-value partner conversion rate
Sales focus on top 20% practices led to ~20% less outreach time
They strategically leveraged Gemini to identify medical practices that fit their growth strategy, using the model to analyze crucial factors like technology adoption, patient demographics, and treatment patterns.
Transparency Evidence & methodology 90/100 reference value · 79% confidence · 1 source

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value90/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth20/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    5 metrics describe measurable impact.
  • Deployment scale5/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence79%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability21/25
    10 of 12 key fields link to a named source.
  • Direct evidence20/20
    5 direct source quotes retained.
  • Date provenance0/10
    The publication date has no documented provenance.
  • Source transparency8/10
    1 source reference document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. Google Cloud

    Clear.bio customer story

    First-party
    https://cloud.google.com/customers/clear-bio
    Source type
    Vendor-published customer story
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes

Date evidence

  • First archived Jun 8, 2026 · Internet Archive · Independent First Wayback Machine capture; confirms the page existed by this date, not when it was published.
    Open date source
  • Sitemap last modified May 28, 2026 · Google Cloud · Publisher metadata Publisher-reported modification timestamp; not a publication date.
    Open date source
Not separately sourced Industry, Region, Company size. Treat these normalized attributes as lower-confidence until a dedicated source is added.